Injectable medications like Zepbound and Wegovy generally offer more significant weight loss results, while oral options like oral Wegovy and Foundayo are appealing for their convenience
The question of stopping patients GLP-1 use before testing comes up frequently these days, but current guidance remains conservative
In this Q&A, Richard Frank, MD, MHSA, Chief Medical Officer at Vida, breaks down what the data actually shows: Oral and injectable semaglutides deliver similar weight loss, safety, and side-effect profiles, with both averaging around 15% weight reduction over more than a year
GersteinHCSattarNRosenstockJRamasundarahettigeCPratleyRLopesRDet al
All research isnt good research, and if a studys outcomes havent been replicated, its hard to imagine any ethical company using it to support the efficacy of their product